A new diagnostic tool has been developed by researchers at The University of Texas at Austin that can easily, quickly and cheaply identify whether a mosquito belongs to the species that carries dangerous diseases such as Zika virus, dengue, chikungunya or yellow fever. It can also determine whether the bug has come into contact with a mosquito-control strategy known as Wolbachia.
“Many of these diseases are spreading in areas where they weren’t common before,” said Sanchita Bhadra, a research associate in the Department of Molecular Biosciences and first author on the paper. “Having surveillance is important in conjunction with any kind of outbreak, and this method allows a rapid test in the field.”
The tool uses a smartphone camera, a small 3D-printed box and a simple chemical test to show whether a dead mosquito belongs to the Aedes aegypti species. Aedes aegypti carries Zika and other devastating viruses that afflict an estimated 100 million people worldwide each year. The species also is closely linked to the tripling of cases of mosquito-borne diseases in the United States since 2004.
The research appears in the journal PLOS Neglected Tropical Diseases.
The tool developed by scientists and students at UT Austin also detects the presence of a biopesticide called Wolbachia, a type of bacteria that keeps mosquitoes from spreading diseases. In countries around the world and in 20 U.S. states where the Aedes aegypti mosquito is found, scientists working in public health agencies have started to infect mosquitoes with Wolbachia by introducing the bacteria into a local mosquito population to help curb transmission of viruses.
Because mosquitoes show no outward signs of having the bacteria – and because existing diagnostic tests are hard to read, expensive and logistically cumbersome – the new tool represents a significant step forward for those hoping to monitor the effectiveness of Wolbachia.
“This test can happen without involving a lot of staff and equipment to make sure Wolbachia is effective and spreading as anticipated,” Bhadra said.
Public health groups trap and kill mosquitoes routinely in conjunction with monitoring efforts, but existing technology requires a complex process to extract nucleic acid from inside mosquitoes, often after they have been dead for days and have started to decay, leading to greater expense and the possibility of more errors in lab tests than the new technology.
The new diagnostic tool uses a smartphone’s camera and a simple test that can be done anywhere. It tests mosquitoes’ nucleic acid without requiring a complicated process to remove it. Officially known as a loop-mediated isothermal amplification and oligonucleotide strand displacement, or LAMP OSD, the probe delivers a simple yes-or-no readout on a cellphone, with accuracy of greater than 97 percent.
In addition to the tests to detect mosquito species and Wolbachia, the team also is exploring use of the technology to easily identify whether trapped mosquitoes are carrying Zika, dengue and other pathogens.
The Latest on: Disease diagnostic tool
via Google News
The Latest on: Disease diagnostic tool
- Global Genetic Disease Diagnostic Market 2020 Report - Trends in Technological Strategies, Business Advancements and Top-Vendor Landscape to 2025on August 10, 2020 at 4:57 pm
Global Genetic Disease Diagnostic Market 2020 by Company, Regions, Type and Application, Forecast to 2025 published by MarketsandResearch.biz is an in-depth analysis of the global market size, ...
- Genomic sequencing as a standalone newborn screening tool falls shorton August 10, 2020 at 8:04 am
With the rise of genomic sequencing, health technology companies are promising parents they can detect rare metabolic disorders in newborns who, despite a healthy appearance, may need immediate ...
- Genomic Sequencing as a Standalone Newborn Screening Tool Falls Short, But May Help Diagnose Uncertain Caseson August 10, 2020 at 8:04 am
Researchers found that, when used alone, sequencing comes up short, missing some sick babies, while flagging many healthy ones for unnecessary follow-up testing. But sequencing can still be useful in ...
- Biomarker for Heart Disease Captured by Novel Nanoparticle Technologyon August 7, 2020 at 1:00 pm
The new University of Wisconsin-Madison method—nanoproteomics—effectively captures and measures various forms of the protein cardiac troponin I, or cTnI, a biomarker of heart damage currently used to ...
- Thyroid cancer diagnosis by Raman spectroscopyon August 7, 2020 at 2:09 am
Over the last 50 years, the incidence of human thyroid cancer disease has seen a significative increment. This comes along with an even higher increment of surgery, since, accordi ...
- Nanoparticle method captures and measures common marker of heart diseaseon August 6, 2020 at 9:58 pm
Madison have developed a method combining sticky nanoparticles with high-precision protein measurement to capture and analyze a common marker of heart disease to reveal details that were previously ...
- Global Infectious Disease Biomarker Testing Market (2020 to 2030) - Analysis and Forecaston August 6, 2020 at 6:00 am
The "Global Infectious Disease Biomarker Testing Market: Focus on Product Type, Technology, Pathogen, Application, End-user, 5 Regional ...
- Global Biomarkers Industry Analysis 2016-2026 by Product, Type, Disease Indication, Application and Regionon August 6, 2020 at 5:54 am
The "Global Biomarkers Market, By Product, Type, Disease Indication, Application, By Region; Trend Analysis, Competitive Market Share & Forecast, 2016-2026" report has been added to ResearchAndMarkets ...
- Ping An AskBob Doctor's Deep Learning Model Improves Diagnosis of Kidney Diseaseon August 4, 2020 at 4:13 am
Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) is pleased to announce that its smart healthcare team  has joined the National Clinical Research Center of Kidney ...
- AC Immune Wins Prestigious Award to Develop a "Game-Changing" Parkinson's Diagnostic Toolon July 30, 2020 at 5:18 am
Availability of non-invasive diagnostic tools like PET imaging agents would allow accurate diagnosis and monitoring of disease progression and would potentially enable longitudinal drug efficacy ...
via Bing News